Elanco CEO on rolling out New World screwworm vaccine: 'We're prepared'

Summary

Elanco CEO Jeffrey Simmons discusses the company's preparedness for the New World screwworm outbreak in the U.S., highlighting public-private partnerships, the USDA stockpile, and their product portfolio including the conditionally approved Cordelia Quatro. He expresses confidence in managing the outbreak and emphasizes the importance of preventive measures for pets.

• Elanco CEO Jeffrey Simmons says the company is prepared to meet demand for screwworm treatments.
• The USDA is creating a stockpile of treatments and coordinating with industry.
• Elanco has the largest portfolio of livestock and pet products and has been serving U.S. cattle for 70 years.
• Cordelia Quatro is a conditionally approved oral treatment for New World screwworm in pets.
• Simmons encourages pet owners to maintain 12-month flea, tick, and heartworm programs.
• The outbreak is currently in early stages and considered manageable.
• Public-private partnerships have been in place since November 2024.